Skip to main content
. 2019 Nov 22;48(1):63–74. doi: 10.1093/nar/gkz1099

Figure 3.

Figure 3.

In vivo activity of anti-ApoB-gapmers in mice liver (left) and kidney (right). Oligonucleotides were dosed 1 mg/kg iv and mice were sacrificed after 7 days (n = 5 per compound).